Inventor · disambiguated record
Andrew Leber
Also filed as: LEBER ANDREW · LEBER ANDREW J
17 granted patents·9 pending applications·14 citations·filing 2018–2024
89Inventor score
Top patents by PatentIndex Score
26 records- 0194US11117881B2Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameLANDOS BIOPHARMA INC·Filed 2020·Granted Sep 14, 2021·2 cites·38 claims
- 0291US10487057B1NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2019·Granted Nov 26, 2019·5 cites·1 claims
- 0389US11180473B2PLXDC2 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Nov 23, 2021·2 cites·55 claims
- 0487US11197891B2Therapies with lanthionine C-like protein 2 ligands and cells prepared therewithLANDOS BIOPHARMA INC·Filed 2018·Granted Dec 14, 2021·2 cites·23 claims
- 0587US10676436B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2019·Granted Jun 9, 2020·2 cites·38 claims
- 0685US11548885B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Jan 10, 2023·1 cites·29 claims
- 0784US2025163017A1Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameNIMMUNE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0881US2024166601A1Nlrx1 ligandsLANDOS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0980US2025163377A1Therapies with lanthionine c-like protein 2 ligands and cells prepared therewithNIMMUNE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1076US12145920B2Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using sameNIMMUNE BIOPHARMA INC·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 1175US11680045B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Jun 20, 2023·0 cites·21 claims
- 1275US11377437B2Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using sameLANDOS BIOPHARMA INC·Filed 2021·Granted Jul 5, 2022·0 cites·30 claims
- 1373US12281096B2Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)NIMMUNE BIOPHARMA INC·Filed 2022·Granted Apr 22, 2025·0 cites·16 claims
- 1472US12145921B2Aromatic immunoregulatory compounds for treatment of inflammatory diseasesNIMML INST·Filed 2022·Granted Nov 19, 2024·0 cites·10 claims
- 1572US11492342B2Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone)LANDOS BIOPHARMA INC·Filed 2021·Granted Nov 8, 2022·0 cites·15 claims
- 1672US2023192652A1Plxdc2 ligandsLANDOS BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1771US12150961B2Therapies with lanthionine C-like protein 2 ligands and cells prepared therewithNIMMUNE BIOPHARMA INC·Filed 2021·Granted Nov 26, 2024·0 cites·15 claims
- 1870US12391673B2LANCL ligandsNIMMUNE BIOPHARMA INC·Filed 2022·Granted Aug 19, 2025·0 cites·26 claims
- 1970US11066364B2NLRX1 ligandsLANDOS BIOPHARMA INC·Filed 2020·Granted Jul 20, 2021·0 cites·30 claims
- 2070US2024368116A1Immunoregulatory compoundsNIMML INST·Filed 2024·Application pending·0 cites
- 2169US11597717B2Substituted imidazoles as PLXDC2 ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Mar 7, 2023·0 cites·31 claims
- 2266US11459310B2LANCL ligandsLANDOS BIOPHARMA INC·Filed 2021·Granted Oct 4, 2022·0 cites·30 claims
- 2366US2023128450A1Nlrx1 ligandsLANDOS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2459US2024270743A1Tetrahydropyrazolopyridine-analog ligands of nlrx1 and uses thereofLANDOS BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2557US2022152019A1Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of surface tissuesLANDOS BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2654US2022335500A1Embeddable recommendation system for cannabis strains and productsSTRAINBRAIN TECH INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Leber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →